(Q27852757)
English
RSF1 and not cyclin D1 gene amplification may predict lack of benefit from adjuvant tamoxifen in high-risk pre-menopausal women in the MA.12 randomized clinical trial
scientific article
- RSF1 and Not Cyclin D1 Gene Amplification May Predict Lack of Benefit from Adjuvant Tamoxifen in High-Risk Pre-Menopausal Women in the MA.12 Randomized Clinical Trial
Statements
2013
0 references
8
0 references
e81740
0 references
12
0 references
19 December 2013
1 reference
1 reference
1 reference
1 reference
1 reference